InsidersTradesSigma
Total declarations
Company
▲ Purchases (28 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
28
Disclosed sells
0
T+90 hit rate
28%
T+90 mean return
-21.7%
Across 25 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by LEE WILLIS C, Chief Executive Officer. Director active across 1 company, notably Emmaus Life Sciences, Inc.. In total, 28 filings have been published. Split: 28 buys · 0 sell. Total volume traded: €117k. History available since 5 May 2021. The latest transaction was filed on 26 February 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations28 total
13,200 shares@ US$0.121.3% of flowCommon stock, $0.001 par valueSEC:0001209191-24-004124:0
Ideal exit: 22 Nov 2024 (T+270)
6,500 shares@ US$0.211.1% of flowCommon stock, $0.001 par valueSEC:0001209191-24-000442:0
Ideal exit: 21 May 2024 (T+270)
1,365 shares@ US$0.210.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-057328:0
Ideal exit: 21 May 2024 (T+270)
750 shares@ US$0.280.2% of flowCommon stock, $0.001 par valueSEC:0001209191-23-033573:0
Ideal exit: 17 Jun 2023 (T+270)
3,200 shares@ US$0.391.0% of flowCommon stock, $0.001 par valueSEC:0001209191-22-043081:0
Ideal exit: 15 Apr 2023 (T+270)
2,500 shares@ US$0.370.11% mcap0.8% of flowCommon stock, $0.001 par valueSEC:0001209191-22-033847:0
Ideal exit: 21 Feb 2023 (T+270)
3,200 shares@ US$0.980.35% mcap2.5% of flowCommon stock, $0.001 par valueSEC:0001209191-22-024129:0
Ideal exit: 30 Dec 2022 (T+270)
500 shares@ US$1.420.078% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-013725:0
Ideal exit: 19 Nov 2022 (T+270)
500 shares@ US$1.540.084% mcap1.3% of flowCommon stock, $0.001 par valueSEC:0001209191-22-001426
Ideal exit: 30 Aug 2022 (T+270)
500 shares@ US$1.540.084% mcap0.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-001426:0
Ideal exit: 30 Aug 2022 (T+270)
24,328 shares@ US$1.453.89% mcap28.0% of flowCommon stock, $0.001 par valueSEC:0001209191-21-067167:0
Ideal exit: 23 Aug 2022 (T+270)
24,328 shares@ US$1.453.89% mcap58.4% of flowCommon stock, $0.001 par valueSEC:0001209191-21-067167
Ideal exit: 23 Aug 2022 (T+270)
3,500 shares@ US$1.320.51% mcap3.7% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066920:0
Ideal exit: 20 Aug 2022 (T+270)
3,500 shares@ US$1.320.51% mcap7.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066920
Ideal exit: 20 Aug 2022 (T+270)
1,600 shares@ US$1.240.21% mcap1.5% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066428:0
Ideal exit: 12 Aug 2022 (T+270)
1,600 shares@ US$1.240.21% mcap3.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-066428
Ideal exit: 12 Aug 2022 (T+270)
2,000 shares@ US$1.510.32% mcap2.3% of flowCommon stock, $0.001 par valueSEC:0001209191-21-056785:0
Ideal exit: 12 Jun 2022 (T+270)
2,000 shares@ US$1.512.2% of flowCommon stock, $0.001 par valueSEC:0001209191-21-056785
Ideal exit: 12 Jun 2022 (T+270)
2,000 shares@ US$1.700.36% mcap2.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-055547:0
Ideal exit: 5 Jun 2022 (T+270)
2,000 shares@ US$1.702.5% of flowCommon stock, $0.001 par valueSEC:0001209191-21-055547
Ideal exit: 5 Jun 2022 (T+270)
2,400 shares@ US$1.512.6% of flowCommon stock, $0.001 par valueSEC:0001209191-21-053681
Ideal exit: 22 May 2022 (T+270)
2,400 shares@ US$1.510.38% mcap2.7% of flowCommon stock, $0.001 par valueSEC:0001209191-21-053681:0
Ideal exit: 22 May 2022 (T+270)
2,700 shares@ US$1.530.42% mcap3.0% of flowCommon stock, $0.001 par valueSEC:0001209191-21-036627:0
Ideal exit: 20 Feb 2022 (T+270)
2,700 shares@ US$1.533.0% of flowCommon stock, $0.001 par valueSEC:0001209191-21-036627
Ideal exit: 20 Feb 2022 (T+270)
1,500 shares@ US$1.141.3% of flowCommon stock, $0.001 par valueSEC:0001209191-21-032183
Ideal exit: 4 Feb 2022 (T+270)
25 of 28 declarations
About LEE WILLIS C
Lee Willis C is an insider at Emmaus Life Sciences, Inc.
